C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1994
12/14/1994	EP0627936A1 Feline infectious peritonitis vaccine and method of preparation
12/14/1994	EP0627934A1 Early antigen for autoimmune diabetes
12/14/1994	EP0627933A1 Bystander suppression of autoimmune diseases
12/14/1994	EP0627929A1 Inhibitors of thrombosis
12/14/1994	EP0627925A1 Trypsin inhibitors
12/14/1994	EP0627924A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
12/14/1994	EP0627923A1 Therapeutic domains of von willebrand factor
12/14/1994	EP0473689B1 Thrombus-targeted complexes of plasminogen activator and fibrin fragments
12/14/1994	EP0471030B1 Glycoprotein hormone receptor molecules
12/14/1994	EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
12/14/1994	EP0371112B1 Isolation and characterisation of genes resistant to anthracycline antibiotics
12/14/1994	EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition
12/14/1994	CN1096326A Preparing method for recomposing streptokinase
12/14/1994	CN1096325A Preparing method for recomposing staphylokinase
12/14/1994	CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases
12/14/1994	CN1026994C Kluyveromyces as a host strain
12/13/1994	US5373090 Aprotinin analogues and a process for the production thereof
12/13/1994	US5373085 Oligopeptide of aspartic acid, glutamic acid, proline, and tryptophan
12/13/1994	US5372997 Albumin preparation and method for preserving the same
12/13/1994	US5372943 Lipid microemulsions for culture media
12/13/1994	US5372933 Antibody-polypeptide immunocomplex
12/13/1994	US5372928 Hepatitis C virus isolates
12/13/1994	US5372809 Antigenic matrix metalloproteinase peptides
12/13/1994	US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
12/13/1994	CA2035389C Bacteriocin peptide
12/11/1994	CA2125536A1 Genetic selection, by means of signal transduction in microorganisms, of proteins which are capable of ligand binding
12/09/1994	CA2125008A1 Peptide and dnas encoding it
12/08/1994	WO1994028413A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	WO1994028391A1 Ligands for flt3 receptors
12/08/1994	WO1994028173A1 Association peptides
12/08/1994	WO1994028172A1 Probes for detection of the fragile x syndrome
12/08/1994	WO1994028166A1 Fluorescence energy transfer substrates
12/08/1994	WO1994028161A1 Antibodies specific for dcc gene product
12/08/1994	WO1994028157A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein
12/08/1994	WO1994028156A1 Compositions and methods for treatment of herpesvirus infections
12/08/1994	WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
12/08/1994	WO1994028152A1 Defective adenoviruses and corresponding complementation lines
12/08/1994	WO1994028151A1 Gene therapy for haemophilia
12/08/1994	WO1994028147A1 Dna sequence comprising at least two coat protein genes
12/08/1994	WO1994028145A2 Expression of urokinase plasminogen activator inhibitors
12/08/1994	WO1994028138A1 Multiple sclerosis virus
12/08/1994	WO1994028137A1 Regulator of contact-mediated hemolysin
12/08/1994	WO1994028136A2 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes
12/08/1994	WO1994028135A1 Process for activating gene expression in bacteria
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028133A1 Recombinant neu differentiation factors
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028131A1 Dna encoding inward rectifier, g-protein activated, mammalian, potassium kga channel and uses thereof
12/08/1994	WO1994028130A1 Gene that codes for polypeptide having ability to support pre-b cell proliferation
12/08/1994	WO1994028129A2 Tumour metastasis gene
12/08/1994	WO1994028127A1 Cancer treatment
12/08/1994	WO1994028126A2 Phenylalanine-free protein and dna coding therefor
12/08/1994	WO1994028125A2 Dna encoding prostaglandin receptor ep1
12/08/1994	WO1994028124A1 Tnf alpha responsive element and tnf alpha induced dna-binding protein which binds to the tnf alpha responsive element
12/08/1994	WO1994028123A1 Mammals lacking expression of cd28 transgenic
12/08/1994	WO1994028122A1 Transgenic mammals lacking expression of particular cd45 isoforms
12/08/1994	WO1994028121A1 Non-human transgenic animal expressing a transferrin of human origin
12/08/1994	WO1994028116A1 Nucleic acid encoding amp-activated protein kinase
12/08/1994	WO1994028114A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO)
12/08/1994	WO1994028026A1 Genetically engineered immunoglobulins
12/08/1994	WO1994028024A1 Carbohydrate-modified polymer conjugates with erythropoietic activity
12/08/1994	WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use
12/08/1994	WO1994028022A1 Novel protein having avidity with heparin-binding growth factor
12/08/1994	WO1994028020A1 A method for the preparation of interferons
12/08/1994	WO1994028019A1 Human calcium sensor
12/08/1994	WO1994028018A2 Synthetic sterically-constrained catalysts
12/08/1994	WO1994028017A1 Human mutant tissue factor compositions useful as tissue factor antagonists
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994028015A1 Lhrh antagonists
12/08/1994	WO1994028013A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock
12/08/1994	WO1994028012A1 Hydroxamate inhibitors of endothelin converting enzyme
12/08/1994	WO1994028009A1 Fragments of neurofibromin (nf1) and method to reverse activated ras induced malignant transformation in mammalian cells
12/08/1994	WO1994028008A1 Novel fluorescent tagging agents
12/08/1994	WO1994027643A1 Envelope fusion vectors for use in gene delivery
12/08/1994	WO1994027641A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	WO1994027638A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/08/1994	WO1994027633A1 Bandage for continuous application of biologicals
12/08/1994	WO1994027613A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	WO1994027498A1 Macromolecular contrast media for mr imaging
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024296A3 Recombinant bovine herpesvirus type 1 vaccines
12/08/1994	WO1994024291A3 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation
12/08/1994	WO1994024283A3 A mammalian guanine nucleotide binding protein with an adp-rybosylation factor domain
12/08/1994	WO1994023638A3 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome
12/08/1994	WO1994021807A3 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
12/08/1994	WO1994021273A3 USE OF ANGIOGENINE, AND/OR α1-MICROGLOBULINE AND/OR COMPLEMENTARY FACTOR D FOR LIMITING PROTEIN SECRETION
12/08/1994	WO1994020604A3 Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same
12/08/1994	WO1994004675A3 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family
12/08/1994	DE4403057C1 Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them
12/08/1994	CA2164428A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	CA2163790A1 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes
12/08/1994	CA2163438A1 Regulator of contact-mediated hemolysin
12/08/1994	CA2163422A1 Antibodies specific for dcc gene product
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163232A1 Macromolecular contrast media for mr imaging
12/08/1994	CA2163227A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	CA2163226A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	CA2163225A1 Lhrh antagonists
12/08/1994	CA2163125A1 Genetically engineered immunoglobulins
12/08/1994	CA2163013A1 Human calcium sensor

1 ... 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 ... 2916